282 CBS-domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 54 | 17.7 | 3.05× | q < 0.0001 | |
| Homogeneous metal compounds | 25 | 31.5 | 0.80× | q = 0.19 | |
| Homogeneous non-metal compounds | 10 | 13.8 | 0.72× | q = 0.36 | |
| Lipids and lipid-like molecules | 3 | 7.1 | 0.42× | q = 0.16 | |
| Organoheterocyclic compounds | 3 | 9.9 | 0.30× | q = 0.03 | |
| Organic acids and derivatives | 1 | 9.9 | 0.10× | q = 1.1e-3 | |
| Organic oxygen compounds | 1 | 12.8 | 0.08× | q < 0.0001 | |
| Organic nitrogen compounds | 1 | 2.0 | 0.49× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 149 |
| DB00131 | AMP | Adenosine phosphate | 130 |
| DB16833 | ADP | Adenosine disphosphate | 54 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 47 |
| DB04022 | G4P | Guanosine tetraphosphate | 16 |
| DB00118 | SAM | Ademetionine | 12 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 11 |
| DB00157 | NAI | NADH | 8 |
| DB14128 | NAD | Nadide | 6 |
| DB01700 | AMZ | AICA ribonucleotide | 5 |
| DB02282 | MTA | 5'-S-methyl-5'-thioadenosine | 4 |
| DB04237 | TAM | Tris(Hydroxyethyl)Aminomethane | 4 |
| DB04482 | CMK | Cmp-2-Keto-3-Deoxy-Octulosonic Acid | 4 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 3 |
| DB00640 | ADN | Adenosine | 2 |
| DB00688 | — | — | 2 |
| DB00811 | — | Ribavirin | 2 |
| DB00133 | — | Serine | 1 |
| DB00151 | — | Cysteine | 1 |
| DB01694 | TAR | D-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 291 |
| AMP | ADENOSINE MONOPHOSPHATE | 137 |
| GTP | GUANOSINE-5'-TRIPHOSPHATE | 119 |
| MGmetal | MAGNESIUM ION | 103 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 55 |
| CL | CHLORIDE ION | 33 |
| G4P | GUANOSINE-5',3'-TETRAPHOSPHATE | 32 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 27 |
| SAM | S-ADENOSYLMETHIONINE | 22 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 17 |
| IMP | INOSINIC ACID | 16 |
| 2BA | (2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide | 13 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 6 |
| C2Z | 5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid | 6 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 6 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 6 |
| AMZ | AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE | 5 |
| 0J1 | (2R)-3-{[(R)-hydroxy{[(1S,2R,3S,4S,5R,6R)-2,3,4,6-tetrahydroxy-5-(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dinonanoate | 4 |
| B4P | BIS(ADENOSINE)-5'-TETRAPHOSPHATE | 4 |
| BR | BROMIDE ION | 4 |